Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHA2 | P29317 | 2/20 | 0.59 |
| ▸ | EP300 | Q09472 | 1/20 | 0.58 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.58 |
| ▸ | NPY2R | P49146 | 7/20 | 0.56 |
| ▸ | NPY4R | P50391 | 7/20 | 0.56 |
| ▸ | NPY5R | Q15761 | 7/20 | 0.56 |
| ▸ | NPY1R | P25929 | 5/20 | 0.56 |
| ▸ | AGTR2 | P50052 | 3/20 | 0.55 |
| ▸ | AGTR1 | P30556 | 2/20 | 0.55 |
| ▸ | KDM1A | O60341 | 2/20 | 0.54 |
| ▸ | NTSR2 | O95665 | 2/20 | 0.53 |
| ▸ | NTSR1 | P30989 | 2/20 | 0.53 |
| ▸ | SORT1 | Q99523 | 1/20 | 0.53 |
| ▸ | MAOB | P27338 | 1/20 | 0.53 |
| ▸ | KDM5A | P29375 | 1/20 | 0.53 |
| ▸ | KDM1B | Q8NB78 | 1/20 | 0.53 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30593545 | 0.90 | EPHA2 (0.63) | EPHA2EP300HIF1ANPY2RNPY4R | |
| SCHEMBL29594926 | 0.90 | NTSR2 (0.57) | EP300HIF1ANTSR2NTSR1SORT1 | |
| SCHEMBL30495601 | 0.88 | NPY2R (0.59) | EPHA2EP300HIF1ANPY2RNPY4R | |
| SCHEMBL30522300 | 0.87 | EPHA2 (0.62) | EPHA2NPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL30640883 | 0.87 | NPY2R (0.58) | EPHA2NPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL31410846 | 0.87 | EPHA2 (0.58) | EPHA2KDM1ANTSR2NTSR1SORT1 | |
| SCHEMBL30571125 | 0.86 | MAPK8 (0.56) | EPHA2EP300HIF1ANPY2RNPY4R | |
| SCHEMBL30607358 | 0.86 | NPY2R (0.69) | EPHA2EP300HIF1ANPY2RNPY4R | |
| SCHEMBL30974204 | 0.85 | EPHA2 (0.57) | EPHA2EP300HIF1ANPY2RNPY4R | |
| SCHEMBL31005053 | 0.85 | EPHA2 (0.57) | EPHA2EP300HIF1ANPY2RNPY4R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12570729-B2 | Antibody fragment based antifungal conjugate selectively targeting candida | ABGENICS LIFESCIENCES PRIVATE LIMITED (IN) | 2026-03-10 | — | — | US | disclosed |
| US-20240092878-A1 | AN ANTIBODY FRAGMENT BASED ANTIFUNGAL CONJUGATE SELECTIVELY TARGETING CANDIDA | ABGENICS LIFESCIENCES PRIVATE LIMITED (IN) | 2024-03-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12570729-B2 | Antibody fragment based antifungal conjugate selectively targeting candida | SERPINH1, HM13, NGLY1 | EPHA2 2738/4885EP300 2247/4885HIF1A 781/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.